CI

At a glance

ClinicalIndex Comparison Record
Phase 3Completed· 120 enrolled
Drug / intervention
Dexmedetomidine +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT05446623
NCT05446623Phase 3Completed

Comparative Study of General Anesthesia With or Without Opioid on the Cardiac Index During Total Hip Arthroplasty

Centre Hospitalier de Montauban·interventional·Posted Jul 6, 2022·Updated Mar 19, 2026

In Brief

A Phase 3 clinical trial evaluating Dexmedetomidine and Sufentanil for Hip Arthropathy and Hip Disease. Completed, enrolled 120 participants across 1 site.

Detailed Summary

General anesthesia used to be based on the association of hypnotics and opioid drugs. But recent studies showed that opioids may be related to a many different complications, like respiratory distress, hyperalgesia. Opioid free anesthesia (OFA) aim is to control de cardiovascular nociceptive response to the surgical stimulation. The scientific literature is not clear yet on the cardiovascular effect of the OFA. Optimization of the cardiac index proved its worth in reducing morbidity and mortality. The purpose of this study is to increase our understanding of the impact of opioid free anesthesia on the cardiovascular system and to evaluate the effectiveness and the security of the technic.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesFrance
Collaborators--

Timeline

Phase 3CompletedFinished
202120222023202420252026
First PostedJul 6, 2022
Enrollment StartJan 1, 2021
Primary CompletionOct 2, 2024
TodayJul 2, 2026
Enrollment to primary: 3.8 yearsPosted 4.0 years ago

Interventions

Dexmedetomidinedrug

Opioid free anesthesia (OFA) consists in the simultaneous administration of alpha2-agonist (for example the dexmedetomidine), sodium channel blocker (lidocaine), and NMDA antagonists receptors (Ketamine). Its aim is to control de cardiovascular nociceptive response to the surgical stimulation.

Sufentanildrug

The one in the OA group will be given a bolus of Sufentanil before and during the surgery.